Riverbridge Partners buys $40,122,853 stake in Zeltiq Aesthetics Inc (ZLTQ)

Zeltiq Aesthetics Inc (ZLTQ) : Riverbridge Partners scooped up 144,781 additional shares in Zeltiq Aesthetics Inc during the most recent quarter end , the firm said in a disclosure report filed with the SEC on Aug 1, 2016. The investment management firm now holds a total of 1,166,362 shares of Zeltiq Aesthetics Inc which is valued at $40,122,853.Zeltiq Aesthetics Inc makes up approximately 0.81% of Riverbridge Partners’s portfolio.

Other Hedge Funds, Including , Tocqueville Asset Management sold out all of its stake in ZLTQ during the most recent quarter. The investment firm sold 17,500 shares of ZLTQ which is valued $594,125.Louisiana State Employees Retirement System boosted its stake in ZLTQ in the latest quarter, The investment management firm added 100 additional shares and now holds a total of 14,300 shares of Zeltiq Aesthetics Inc which is valued at $481,481. Zeltiq Aesthetics Inc makes up approx 0.02% of Louisiana State Employees Retirement System’s portfolio.Ls Investment Advisors boosted its stake in ZLTQ in the latest quarter, The investment management firm added 145 additional shares and now holds a total of 1,361 shares of Zeltiq Aesthetics Inc which is valued at $44,314.Wealthtrust-arizona boosted its stake in ZLTQ in the latest quarter, The investment management firm added 65 additional shares and now holds a total of 303 shares of Zeltiq Aesthetics Inc which is valued at $9,866. Zeltiq Aesthetics Inc makes up approx 0.01% of Wealthtrust-arizona’s portfolio.

Zeltiq Aesthetics Inc opened for trading at $34.41 and hit $35.15 on the upside on Thursday, eventually ending the session at $34.5, with a gain of 0.29% or 0.1 points. The heightened volatility saw the trading volume jump to 7,16,834 shares. Company has a market cap of $1,361 M.

On the company’s financial health, Zeltiq Aesthetics Inc reported $-0.25 EPS for the quarter, missing the analyst consensus estimate by $ -0.01 based on the information available during the earnings call on May 10, 2016. Analyst had a consensus of $-0.24. The company had revenue of $64.50 million for the quarter, compared to analysts expectations of $61.87 million. The company’s revenue was up 25.0% compared to the same quarter last year. During the same quarter in the previous year, the company posted $-0.06 EPS.

ZELTIQ Aesthetics Inc. is a medical technology company. The Company is focused on developing and commercializing products utilizing its controlled-cooling technology platform. Its commercial product the CoolSculpting System is designed to reduce stubborn fat bulges. The Company sells its CoolSculpting system to dermatologists plastic surgeons and aesthetic specialists and generates revenue from sales of its CoolSculpting system and from sales of consumables to its customers. Consumables are the CoolSculpting procedure packs that it sells which are needed to perform procedures using its CoolSculpting system. As of December 31 2014 it had an installed base of 3176 CoolSculpting systems installed across approximately 2688 practices across the world. As of December 31 2014 1.5 million CoolSculpting cycles had been shipped to its customers and distributors.

Leave a Reply

Zeltiq Aesthetics Inc - Is it time to Sell?

Top Brokerage Firms are advising their investors on Zeltiq Aesthetics Inc. Subscribe to MoneyFlowIndex.Org Pre-Market Alerts, You will be the first to know the street buzz.